Bluefin Capital Management LLC Purchases New Shares in The Cooper Companies, Inc. $COO

Bluefin Capital Management LLC purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 12,500 shares of the medical device company’s stock, valued at approximately $896,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in COO. BlackRock Inc. acquired a new position in Cooper Companies in the 2nd quarter worth $1,077,762,000. Generation Investment Management LLP acquired a new stake in shares of Cooper Companies during the second quarter valued at about $356,304,000. Wellington Management Group LLP grew its stake in shares of Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after acquiring an additional 4,756,178 shares in the last quarter. Jupiter Topco LLC purchased a new stake in shares of Cooper Companies during the second quarter worth about $305,074,000. Finally, Diamond Hill Capital Management Inc. increased its position in shares of Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after acquiring an additional 2,720,594 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO opened at $72.68 on Thursday. The business’s fifty day moving average price is $72.36 and its 200 day moving average price is $70.96. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The stock has a market capitalization of $14.17 billion, a PE ratio of 61.59, a price-to-earnings-growth ratio of 1.91 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the firm earned $0.96 earnings per share. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Wall Street Analyst Weigh In

COO has been the subject of a number of analyst reports. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a report on Wednesday, May 27th. BNP Paribas Exane dropped their price objective on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a report on Monday, June 8th. Stifel Nicolaus cut their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Wells Fargo & Company reiterated a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $81.64.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.